Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target

CAMBRIDGE, Mass., Feb. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 million in Ser... Biopharmaceuticals, Venture Capital Cellarity
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news